Nathan Treybeck
Stock Analyst at Wells Fargo
(0.65)
# 4,080
Out of 4,596 analysts
66
Total ratings
28.2%
Success rate
-5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Rated: Hold | $227 → $225 | $210.98 | +6.65% | 3 | Jul 8, 2026 | |
| PRCT PROCEPT BioRobotics | Rated: Buy | $34 | $18.62 | +82.60% | 25 | Jul 2, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Hold | $94 → $104 | $101.32 | +2.65% | 8 | May 6, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $225 → $200 | $117.17 | +70.69% | 19 | Feb 20, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | $132 → $80 | $121.21 | -34.00% | 11 | Oct 23, 2025 |
ResMed
Jul 8, 2026
Rated: Hold
Price Target: $227 → $225
Current: $210.98
Upside: +6.65%
PROCEPT BioRobotics
Jul 2, 2026
Rated: Buy
Price Target: $34
Current: $18.62
Upside: +82.60%
LeMaitre Vascular
May 6, 2026
Maintained: Hold
Price Target: $94 → $104
Current: $101.32
Upside: +2.65%
iRhythm Holdings
Feb 20, 2026
Maintained: Buy
Price Target: $225 → $200
Current: $117.17
Upside: +70.69%
Integer Holdings
Oct 23, 2025
Downgraded: Hold
Price Target: $132 → $80
Current: $121.21
Upside: -34.00%